Citius Pharmaceuticals, Inc. Increase (Decrease) in Employee Related Liabilities
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Employee Related Liabilities of -$1.42 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was -$1.73M, a 429.04% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was $507.61K, a 13.81% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$198.05K, a 154.10% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was -$417.59K, a 179.34% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $1.06M, a 1376.27% increase from fiscal 2024.
- Citius Pharmaceuticals, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $72.03K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$1.22M derived: sum of 2 quarters · filed 2026-08-14 | -$1.42M 10-Q · filed 2026-08-14 | -$1.84M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $507.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $309.56K 10-Q · filed 2026-05-15 | -$108.03K derived: sum of 3 quarters · filed 2026-05-15 | $417.94K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$198.05K 10-Q · filed 2026-02-13 | -$615.65K derived: sum of 2 quarters · filed 2026-02-13 | -$89.67K derived: sum of 3 quarters · filed 2026-08-14 | $499.30K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | -$417.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $108.38K derived: sum of 2 quarters · filed 2026-08-14 | $697.36K derived: sum of 3 quarters · filed 2026-08-14 | $1.06M 10-K · filed 2025-12-23 |
| 2025-06-30 | $525.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $1.11M derived: sum of 2 quarters · filed 2026-08-14 | $1.48M 10-Q · filed 2026-08-14 | $2.01M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $588.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $955.05K 10-Q · filed 2026-05-15 | $1.48M derived: sum of 3 quarters · filed 2026-05-15 | $2.06M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $366.07K 10-Q · filed 2026-02-13 | $892.42K derived: sum of 2 quarters · filed 2026-02-13 | $1.47M derived: sum of 3 quarters · filed 2026-02-13 | |
| 2024-09-30 | $526.35K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $1.11M derived: sum of 2 quarters · filed 2025-12-23 | $72.03K 10-K · filed 2025-12-23 | |
| 2024-06-30 | $579.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$454.31K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$1.03M 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |